All News

2020

May

Media Release / May 28, 2020

Novartis data highlight benefit of early treatment initiation in patients with secondary progressive multiple sclerosis (SPMS)

Read More
Illustration of the coronavirus created at the Centers for Disease Control and Prevention (CDC)
Featured News / May 27, 2020

Coronavirus (COVID-19) news feed

Read More
Featured News / May 27, 2020

Novartis update following WHO Solidarity trial announcement

Read More
Woman at a work bench
Featured News / May 27, 2020

Novartis at ASCO

Latest oncology resources and news surrounding Novartis data featured at American Society of Clinical Oncology (ASCO)

Read More
Media Release / May 27, 2020

Novartis Kisqali® shows overall survival benefit in HR+/HER2- advanced breast cancer with consistent findings in patients with more aggressive disease

Read More
Media Release / May 27, 2020

Novartis announces new late-breaking ofatumumab data at EAN demonstrating robust efficacy and safety in the treatment of relapsing forms of multiple sclerosis (RMS)

Read More
Media Release / May 26, 2020

Novartis study reveals that migraine support in the workspace can significantly decrease the impact of the disease on affected employees

Read More
Media Release / May 19, 2020

AveXis receives EC approval and activates “Day One” access program for Zolgensma®, the only gene therapy for spinal muscular atrophy (SMA)

Read More
Media Release / May 14, 2020

Novartis data at ASCO and EHA showcase bold approaches to reimagine cancer and blood disorders through multiple therapeutic platforms

Read More
3D rendering of COVID-19, the novel coronavirus causing the pand
Story / May 12, 2020

Moving from speculation to science during a pandemic

Florencia Segal’s experiences prepared her to lead the rapid design of a large COVID-19 clinical trial.

Read More

Related Links

Novartis Annual Reporting Suite

Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society report.

Learn More